Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, July 18, 2024 | Back issues
Courthouse News Service Courthouse News Service

Birth Control

The Second Circuit upheld a ruling in favor of pharmaceutical company Bayer in a class action products liability dispute over the Mirena intrauterine device. The plaintiffs, who claimed the IUD caused them to develop idiopathic intracranial hypertension, failed to present reliable expert opinions.

MANHATTAN — The Second Circuit upheld a ruling in favor of pharmaceutical company Bayer in a class action product liability dispute over the Mirena intrauterine device. The plaintiffs, who claimed the IUD caused them to develop idiopathic intracranial hypertension, failed to present reliable expert opinions. 

Categories / Appeals, Business, Health

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...